Business
Press Release Jan 28 2026
Shilpa Medicare Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Shilpa Medicare and mAbTree Biologics receive FDA Orphan Drug Designation, Advancing Treatment for Rare Blood Cancers".
About this update from Shilpa Medicare Limited
[{"type":"text","content":" Shilpa Medicare Limited has informed the Exchange regarding a press release dated January 28, 2026, titled \"Shilpa Medicare and mAbTree Biologics receive FDA Orphan Drug Designation, Advancing Treatment for Rare Blood Cancers\". View Attachment","length":376,"tagName":"div"}]